Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer

**Background:** Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non–muscle invasive bladder cancer (NMIBC), but is associated with a substantial emotional, physical, and social burden. **Objectives:** This study evaluated the adequacy of first...

Full description

Saved in:
Bibliographic Details
Main Authors: Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2024-10-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.124208
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.36469/001c.124208

Similar Items